Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma Multiforme

Explore clinical trials studying Glioblastoma Multiforme. Study availability and eligibility vary by location and protocol.

281 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma Multiforme trial results

Completed

Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme

NCT00590681

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • The University of Chicago Chicago, Illinois, United States
  • NorthShore University health system Evanston, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Medical college of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

NCT00031083

Conditions
Adenoviridae Infections, Anaplastic Astrocytoma, Astrocytoma, +22 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona at Tucson Tucson, Arizona, United States
  • University of Colorado Health Sciences Center Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma

NCT02590263

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +17 more
Locations
  • Nagoya University Hospital /ID# 138559 Nagoya, Aichi-ken, Japan
  • Hiroshima University Hospital /ID# 139399 Hiroshima, Japan
  • Hokkaido University Hospital /ID# 150589 Sapporo, Hokkaido, Japan
  • University of Tsukuba Hospital /ID# 140433 Tsukuba, Ibaraki, Japan
View all 22 locations
View Trial Details
Completed

Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

NCT00402116

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician San Francisco, California, United States
View Trial Details
Completed

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

NCT01349660

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • Yale School of Medicine New Haven, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
  • Florida Cancer Specialists St. Petersburg, Florida, United States
View Trial Details
Completed

Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors

NCT02502708

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +24 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
  • Children's Heathcare of Atlanta Atlanta, Georgia, United States
  • Augusta University Augusta, Georgia, United States
View Trial Details

Related conditions